• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对聚合酶链反应检测艰难梭菌感染重复粪便检测的评估。

An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction.

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

出版信息

J Clin Gastroenterol. 2012 Nov-Dec;46(10):846-9. doi: 10.1097/MCG.0b013e3182432273.

DOI:10.1097/MCG.0b013e3182432273
PMID:22334221
Abstract

GOALS

To evaluate the yield of repeat stool polymerase chain reaction (PCR) testing in patients with suspected Clostridium difficile infection (CDI).

BACKGROUND

CDI is a major challenge in health care due to its frequent occurrence and high associated costs. Enzyme immunoassay and PCR are commonly performed diagnostic tests for CDI.

METHODS

Our microbiology laboratory database was queried from January 1, 2008 to June 30, 2010 for all patients who underwent PCR stool testing for suspected CDI. Data collected included age, sex, number of stool tests performed within a 14-day period after the first test, and location of patient (inpatient vs. outpatient). Analyses were performed using JMP version 9.0.1.

RESULTS

PCR testing was performed in 15,515 patients. The median age was 58.3 years (range, 10 d to 104.3 y) and 46.2% of patients were women. Repeat testing was infrequent; 87.3% of patients had testing performed only once in a 14-day period. Increased age, male sex, and inpatient location were predictors of repeat testing. The median time between an initial test and the first repeat test was 5 days. After an initial negative test, the percentage of patients having a subsequent positive test was low (2.7% in 7 d and 3.2% in 14 d). The percentage of repeat tests that was positive within 7 days (2.9%) was lower than the percentage that was positive from day 8 to day 14 (4.8%, P=0.05).

CONCLUSIONS

Repeat testing for C. difficile has a low yield, and patients with an initial negative test should not routinely be retested.

摘要

目的

评估疑似艰难梭菌感染(CDI)患者重复粪便聚合酶链反应(PCR)检测的效果。

背景

由于 CDI 频繁发生且相关费用高,因此它是医疗保健中的一个主要挑战。酶联免疫吸附试验和 PCR 是常用于 CDI 的诊断检测方法。

方法

我们的微生物实验室数据库从 2008 年 1 月 1 日至 2010 年 6 月 30 日对所有进行 PCR 粪便检测以疑似 CDI 的患者进行了查询。收集的数据包括年龄、性别、首次检测后 14 天内进行的粪便检测次数以及患者的位置(住院患者与门诊患者)。使用 JMP 版本 9.0.1 进行分析。

结果

对 15515 名患者进行了 PCR 检测。中位年龄为 58.3 岁(范围 10 天至 104.3 岁),46.2%的患者为女性。重复检测的频率较低;87.3%的患者在 14 天内仅进行了一次检测。年龄较大、男性和住院患者的位置是重复检测的预测因素。初始检测与首次重复检测之间的中位时间为 5 天。初始检测呈阴性后,随后呈阳性的患者比例较低(7 天内为 2.7%,14 天内为 3.2%)。在 7 天内呈阳性的重复检测比例(2.9%)低于第 8 天至第 14 天呈阳性的比例(4.8%,P=0.05)。

结论

艰难梭菌的重复检测效果不佳,初始检测呈阴性的患者不应常规进行重复检测。

相似文献

1
An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction.对聚合酶链反应检测艰难梭菌感染重复粪便检测的评估。
J Clin Gastroenterol. 2012 Nov-Dec;46(10):846-9. doi: 10.1097/MCG.0b013e3182432273.
2
Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.重复酶免疫测定在艰难梭菌感染中的诊断价值
Am J Gastroenterol. 2009 Aug;104(8):2035-41. doi: 10.1038/ajg.2009.174. Epub 2009 Apr 14.
3
[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].[对从马尔马拉大学医院腹泻住院患者中分离出的艰难梭菌菌株毒素基因的研究]
Mikrobiyol Bul. 2011 Jan;45(1):1-10.
4
Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.采用酶免疫分析法重复粪便检测诊断艰难梭菌感染并不能提高诊断率。
Clin Gastroenterol Hepatol. 2011 Aug;9(8):665-669.e1. doi: 10.1016/j.cgh.2011.04.030. Epub 2011 May 13.
5
Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.两步谷氨酸脱氢酶抗原实时聚合酶链反应检测产毒艰难梭菌。
J Hosp Infect. 2010 Jan;74(1):48-54. doi: 10.1016/j.jhin.2009.08.014. Epub 2009 Nov 8.
6
Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?经验性治疗是否会导致艰难梭菌感染(CDI)诊断检测结果呈假阴性?
Clin Infect Dis. 2013 Aug;57(4):494-500. doi: 10.1093/cid/cit286. Epub 2013 May 3.
7
Repeat stool testing for Clostridium difficile using enzyme immunoassay in patients with inflammatory bowel disease increases diagnostic yield.在炎症性肠病患者中,使用酶联免疫吸附试验重复检测艰难梭菌可提高诊断率。
Curr Med Res Opin. 2012 Sep;28(9):1553-60. doi: 10.1185/03007995.2012.717529. Epub 2012 Aug 23.
8
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.社区获得性艰难梭菌感染的流行病学,2009 年至 2011 年。
JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.
9
Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.产毒艰难梭菌聚合酶链反应检测对临床微生物学实验室和住院患者流行病学的影响。
Diagn Microbiol Infect Dis. 2013 Aug;76(4):534-8. doi: 10.1016/j.diagmicrobio.2013.04.020. Epub 2013 Jun 2.
10
Evaluation of a rapid molecular screening approach for the detection of toxigenic Clostridium difficile in general and subsequent identification of the tcdC Δ117 mutation in human stools.评价一种快速分子筛选方法在检测普通人和随后在人类粪便中鉴定 tcdC Δ117 突变的产毒艰难梭菌中的应用。
J Microbiol Methods. 2010 Oct;83(1):59-65. doi: 10.1016/j.mimet.2010.07.017. Epub 2010 Jul 30.

引用本文的文献

1
Diagnostic Guidance for C. difficile Infections.艰难梭菌感染的诊断指南。
Adv Exp Med Biol. 2024;1435:33-56. doi: 10.1007/978-3-031-42108-2_3.
2
South African Society of Clinical Microbiology infection diagnosis, management and infection prevention and control guideline.南非临床微生物学会感染诊断、管理及感染预防与控制指南。
S Afr J Infect Dis. 2020 Oct 28;35(1):219. doi: 10.4102/sajid.v35i1.219. eCollection 2020.
3
A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of () in Adults.
一项关于核酸扩增检测(NAATs)和包括 NAATs 在内的算法在诊断成人()中的实验室医学最佳实践系统评价和荟萃分析。
Clin Microbiol Rev. 2019 May 29;32(3). doi: 10.1128/CMR.00032-18. Print 2019 Jun 19.
4
Clostridium difficile infection: Updates in management.艰难梭菌感染:管理方面的最新进展
Indian J Gastroenterol. 2017 Jan;36(1):3-10. doi: 10.1007/s12664-016-0719-z. Epub 2016 Dec 20.
5
Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.用于粪便中产毒艰难梭菌分子检测的新型便携式平台:一项诊断准确性研究。
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):783-789. doi: 10.1007/s10096-016-2860-0. Epub 2016 Dec 17.
6
[Diagnostic workup and therapy of infectious diarrhea. Current standards].[感染性腹泻的诊断检查与治疗。现行标准]
Internist (Berl). 2015 Dec;56(12):1353-60. doi: 10.1007/s00108-015-3756-2.
7
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.分子检测时代艰难梭菌感染的过度诊断
JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.
8
Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized Patients.住院患者艰难梭菌感染短期风险相关的特征及抗生素使用情况
Am J Clin Pathol. 2015 Jun;143(6):895-900. doi: 10.1309/AJCP9EWI6QPVTPQY.
9
Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Bacterial Gastroenteritis.临床微生物实验室实用指南:细菌性胃肠炎的诊断
Clin Microbiol Rev. 2015 Jan;28(1):3-31. doi: 10.1128/CMR.00073-14.
10
Clinical characteristics of patients who test positive for Clostridium difficile by repeat PCR.重复 PCR 检测阳性的艰难梭菌患者的临床特征。
J Clin Microbiol. 2014 Nov;52(11):3853-5. doi: 10.1128/JCM.01659-14. Epub 2014 Aug 13.